Franklin et al. analyzed the expression pattern of SLC39A1 in several prostate cancer cell lines and speculated that the downregulation is likely own to in situ gene silencing based o the fact that all the malignant cell lines tended to express low SLC39A1 [19]. This evidence concerns the gene SLC39A1 and Familial prostate cancer.